Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

MDGL Company Profile and Key Details

NASDAQ : MDGL

Madrigal Pharmaceuticals

$289.88
-4.52-1.53%
At Close 4:00 PM
71.22
BESG ScoreESG Rating
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

Price Chart

Stock Price Today

Madrigal Pharmaceuticals, Inc. (MDGL) stock declined over -1.54%, trading at $289.88 on NASDAQ, down from the previous close of $294.40. The stock opened at $297.00, fluctuating between $286.44 and $299.94 in the recent session.

Stock Snapshot

294.4
Prev. Close
6.44B
Market Cap
286.44
Day Low
-16.25
P/E Ratio
-17.84
EPS (TTM)
-16.48
Cash Flow per Share
297
Open
22.2M
Number of Shares
299.94
Day High
90.44%
Free Float in %
20.51
Book Value
507.83K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Jul 30, 2025297.00302.00286.44289.88535.16K
Jul 29, 2025295.42298.29288.88294.40259.85K
Jul 28, 2025299.57305.59293.85294.16292.48K
Jul 25, 2025298.92301.82296.17298.40300.05K
Jul 24, 2025309.83312.00298.79299.17360.08K
Jul 23, 2025314.58324.00306.35306.76375.22K
Jul 22, 2025329.50332.75312.50313.40583.52K
Jul 21, 2025334.02337.40328.53330.94232.2K
Jul 18, 2025350.00351.20331.24334.13326.01K
Jul 17, 2025343.00352.00343.00348.73361.94K
Jul 16, 2025327.15357.91327.15344.971.3M
Jul 15, 2025322.50322.50307.43311.14273.76K
Jul 14, 2025315.04327.59314.57319.87316.92K
Jul 11, 2025311.88316.96309.62315.46163.77K
Jul 10, 2025308.46314.86305.02314.64188.65K
Jul 09, 2025290.61310.00290.61308.59351.8K
Jul 08, 2025289.53292.29285.00287.52250.72K
Jul 07, 2025297.81297.81284.02289.17176.16K
Jul 03, 2025302.01304.00298.00298.87108.52K
Jul 02, 2025299.52311.21295.43300.15340.91K

Contact Details

West Conshohocken, PA 19428

United States

https://www.madrigalpharma.com267 824 2827

About Company

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Company Information

Employees528
Beta-1.08
Sales or Revenue$0.00
5Y Sales Change%0%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Madrigal Pharmaceuticals, Inc. (MDGL) stock price?
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) stock price is $289.88 in the last trading session. During the trading session, MDGL stock reached the peak price of $299.94 while $286.44 was the lowest point it dropped to. The percentage change in MDGL stock occurred in the recent session was -1.54% while the dollar amount for the price change in MDGL stock was -$4.52.
MDGL's industry and sector of operation?
The NASDAQ listed MDGL is part of Biotechnology industry that operates in the broader Healthcare sector. Madrigal Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of MDGL?
Mr. Thomas W. Hare
Senior Vice President of Clinical Management
Mr. Remy Sukhija
Senior Vice President & Chief Commercial Officer
Mr. Edward Chiang
Senior Vice President of Clinical & Technical Operations
Dr. Rebecca A. Taub M.D.
Founder, Chief Medical Officer, Pres of R&D and Director
Dr. Stephen Dodge M.B.A., Pharm.D.
Senior Vice President of Global Medical Affairs
Dr. Paul A. Friedman M.D.
Chairman & Chief Executive Officer
Dr. Kianoush Motesharei Ph.d.
Senior Vice President of Bus. & Corporation Devel.
Mr. Alex G. Howarth
Senior Vice President & Chief Financial Officer
Dr. Robert E. Waltermire Ph.D.
Chief Pharmaceutical Devel. Officer
Mr. Brian J. Lynch J.D.
Senior Vice President & Gen. Counsel
How MDGL did perform over past 52-week?
MDGL's closing price is 44.48% higher than its 52-week low of $200.63 where as its distance from 52-week high of $377.46 is -23.2%.
How many employees does MDGL have?
Number of MDGL employees currently stands at 528.
Link for MDGL official website?
Official Website of MDGL is: https://www.madrigalpharma.com
How do I contact MDGL?
MDGL could be contacted at phone 267 824 2827 and can also be accessed through its website. MDGL operates from Four Tower Bridge, West Conshohocken, PA 19428, United States.
How many shares of MDGL are traded daily?
MDGL stock volume for the day was 507.83K shares. The average number of MDGL shares traded daily for last 3 months was 341.38K.
What is the market cap of MDGL currently?
The market value of MDGL currently stands at $6.44B with its latest stock price at $289.88 and 22.2M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings Calendar
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph